Development and validation of a machine learning-based risk model for metastatic disease in NmCRPC patients: a tumour marker prognostic study
{{output}}
Background: Nonmetastatic castration-resistant prostate cancer (nmCRPC) is a clinical challenge due to the high progression rate to metastasis and mortality. To date, no prognostic model has been developed to predict the metastat... ...
